Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91K Sell
452
-260
-37% -$978 ﹤0.01% 7233
2026
Q1
$2.7K Buy
+712
New +$2.06K ﹤0.01% 6966
2021
Q2
Sell
-34,360
Closed -$617K 6307
2021
Q1
$617K Buy
+34,360
New +$783K ﹤0.01% 4548

Other funds holding ADAG

JP Morgan Chase's ADAG Position: Q2 2026 in Review

JP Morgan Chase reduced its Adagene (ADAG) stake by 37% in Q2 2026, selling an estimated $978 and leaving 452 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7233.

JP Morgan Chase first reported a position in ADAG in Q1 2021 and has held it in 3 quarters since. The position peaked at $617K in Q1 2021. 36 funds tracked by Wall St. Rank hold ADAG as of Q2 2026.

  • JP Morgan Chase held 452 shares of Adagene worth $1.91K as of Q2 2026.
  • JP Morgan Chase sold 260 Adagene shares in Q2 2026, an estimated $978.
  • Adagene made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7233 holding.
  • JP Morgan Chase first reported a position in Adagene in Q1 2021 and has held it in 3 quarters since.
  • JP Morgan Chase's Adagene position peaked at $617K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Adagene as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.